Skip to main content

Table 2 Metabolic Characteristics of all patients

From: Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population

 

Case Control

T2DM

CHD

N

50

35

22

Fasting Glucose mmol/L

5.4(1.4)

15.4(5.4)a

5.6(0.6)

Cholesterol mmol/L

5.3(1.3)

6.9(1.9)b

7.7(2.7)c

HDL mmol/L

0.9(0.4)

0.88(0.3)

0.92(0.4)

Triglyceride mmol/L

1.8(0.6)

2.5(1.1)

2.1(1.2)

LDL mmol/L

3.9(1.4)

6.1(2.9)d

4.9(1.9)e

Insulin (Range) μmol/L*

7.5(5–12)

9.0(9–16)

7.0(1–49)

Leptin (Range)ng/mL*

7.2(2–30)

5.8(1.9–28)

3.7(0.7–8.9)

Apo1 mg/dL

80.1(15.6)

70.8.(23.4)c

74.1(24.5)

Apo11 mg/dL

48.7(13.5)

45.9(13.6)f

46.3(18.9)c

HOMAIR (Range)*

1.8(1.3–3.2)

8.2(0.8–49.7)

2.0(0.5–5.6)

Resistin ng/mL

18.9(3.4)

22.6(4.5)e

24.2(3.2)d

CRP (Range) μg/mL*

4.9(0.2–18.9)

8.2(0.7–27.1)g

7.3(1.8–18.3)f

  1. Data are presented as means (SD) or as median (interquartile range) for insulin, leptin HOMIR and CRP data. P-values shown are comparison of metabolic characteristics for case control versus either type 2 diabetic (T2DM) or coronary heart disease (CHD) patients as highlighted: a = p < 0.0001, b = p < 0.05, c = p < 0.003, d = p < 0.017, e = p < 0.01, f = p < 0.002, g = p < 0.007.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840